[ Pharmacologic therapy for inflammatory bowel diseases : hopes , disappointments ] . Because the etiology of inflammatory bowel diseases is unclear , no causative therapy is available . However , pathophysiology of the disease offers a lot of possibilities to disrupt the inflammatory cascade that maintains the inflammatory process . The aim of every therapy is to maintain remission as long as possible and to amend the natural course of the disease . Pharmacotherapy includes 5-Aminosalicylates , glucocorticoids , immunosupressants ( methotrexate , azathioprine ) as well as specific pharmacologic interventions like monoclonal antibodies directed against P01375 ( DB00065 ) . Important supportive tools are available to improve symptoms like diarrhea and pain . Dietetic treatment and surgical procedures represent important alternatives or supplement pharmacotherapeutic interventions .